Literature DB >> 16900752

Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter.

G Haddock1, A K Cross, J Plumb, J Surr, D J Buttle, R A D Bunning, M N Woodroofe.   

Abstract

ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) -1, -4 and -5 proteases have been identified in the CNS at the mRNA level. These glutamyl endopeptidases, inhibited by tissue inhibitor of metalloproteinases (TIMP)-3, are key enzymes in the degradation of the aggregating chondroitin sulphate proteoglycans (CSPGs), and may therefore play a role in CNS extracellular matrix (ECM) changes in multiple sclerosis (MS). We have investigated ADAMTS and TIMP-3 expression in normal and MS CNS white matter by real-time RT-PCR, western blotting and immunohistochemistry. We report for the first time the presence of ADAMTS-1, -4 and -5 in normal and MS white matter. Levels of ADAMTS-1 and -5 mRNA were decreased in MS compared to normal tissue, with no significant change in ADAMTS-4 mRNA levels. Protein levels of ADAMTS-4 were significantly higher in MS tissue compared to normal tissue. Immunohistochemical studies demonstrated that ADAMTS-4 was associated predominantly with astrocytes with increased expression within MS lesions. TIMP-3 mRNA was significantly decreased in MS compared to controls. These studies suggest a role for ADAMTS-4 in the pathogenesis of MS. Further studies on the activity of ADAMTS-4 will enable a better understanding of its role in the turnover of the ECM of white matter in MS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900752     DOI: 10.1191/135248506ms1300oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 2.  Astrocyte, the star avatar: redefined.

Authors:  Pankaj Seth; Nitin Koul
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

Review 3.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

4.  Pathway-Focused Profiling of Oligodendrocytes Over-Expressing miR-125a-3p Reveals Alteration of Wnt and Cell-to-Cell Signaling.

Authors:  Maria P Abbracchio; Davide Lecca; Davide Marangon
Journal:  Cell Mol Neurobiol       Date:  2020-04-01       Impact factor: 5.046

Review 5.  Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease.

Authors:  Murat Serdar Gurses; Mustafa Numan Ural; Mehmet Akif Gulec; Omer Akyol; Sumeyya Akyol
Journal:  Aging Dis       Date:  2016-01-11       Impact factor: 6.745

6.  Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.

Authors:  Erin E McCandless; Laura Piccio; B Mark Woerner; Robert E Schmidt; Joshua B Rubin; Anne H Cross; Robyn S Klein
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

7.  Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension.

Authors:  Michelle G Hamel; Joanne M Ajmo; Christopher C Leonardo; Fengrong Zuo; John D Sandy; Paul E Gottschall
Journal:  Exp Neurol       Date:  2007-12-03       Impact factor: 5.330

Review 8.  ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Authors:  Sighild Lemarchant; Mathilde Pruvost; Joan Montaner; Evelyne Emery; Denis Vivien; Katja Kanninen; Jari Koistinaho
Journal:  J Neuroinflammation       Date:  2013-10-31       Impact factor: 8.322

9.  ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.

Authors:  Sighild Lemarchant; Yuriy Pomeshchik; Iurii Kidin; Virve Kärkkäinen; Piia Valonen; Sarka Lehtonen; Gundars Goldsteins; Tarja Malm; Katja Kanninen; Jari Koistinaho
Journal:  Mol Neurodegener       Date:  2016-01-25       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.